Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro

American Journal of Chinese Medicine

Volumn 35, Issue 3, 2007, Pages 533-541

  Chen, Yu Cheng ^a,c   Ho, Chien Yi ^b,c   Chen, Lieh Der ^c   Hsu, Sheng Feng ^c   Chen, Wen Chi ^b,c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Calcium oxalate; Polyporus umbellatus Fries; Poria cocos Wolf; Urinary stone; Wu Ling San formula

Indexed keywords

ALISMATIS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; CALCIUM OXALATE; CHINESE DRUG; CINNAMOMUM CASSIA EXTRACT; PLANT EXTRACT; POLYPORUS UMBELLATUS EXTRACT; PORIA COCOS EXTRACT; UNCLASSIFIED DRUG; WU LING SAN;

ALISMATIS; ARTICLE; ATRACTYLODIS MACROCEPHALAE; CINNAMOMI CASSIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLIZATION; FUNGUS; GROWTH; IN VITRO STUDY; MEDICINAL PLANT; POLYPORUS UMBELLATUS; RECURRENT DISEASE; SPECTROPHOTOMETRY; UROLITHIASIS;

CALCIUM OXALATE; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; PARTICLE SIZE; SPECTROPHOTOMETRY;

EID: 34347403454     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X07005041     Document Type: Article

References (25)

1. Asplin, J.R., D.A. Bushinsky, W. Singharetnam, D. Riordon, J.H. Parks and F.L. Coe. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 51: 640-645, 1997.
2. Atmani, F. and S.R. Khan. Effect of an extract from Herniaria hirsute on calcium oxalate crystallisation in vitro. Br. J. Urol. Int. 85: 621-625, 2000.
3. Barcelo, P., O. Wuhl, E. Servitge, A. Rousaud and C.Y. Pak. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J. Urol. 150: 1761-1764, 1993.
4. Bernhard, H. and J.K. Dirk. Nucleation, growth, and aggregation of stone-forming crystals. In: F.L. Coe, M.J. Favus, C.Y.C. Pak, J.H. Parks and G.M. Preminger (eds.) Kidney Stone: Medical and Surgical Management. Lippincott-Raven Publishers, Philadelphia, 1996, pp. 3-32.
5. Bretherton, T. and A. Rodgers. Crystallization of calcium oxalate in minimally diluted urine. Cryst. Growth 192: 448-455, 1998.
6. Chen, W.C., C.C. Shih, W.A. Lu, P.C. Li, C.J. Chen, S. Hayakawa, K. Shimizu and T. Chien. Combination of Wu Lin San and Shan Zha ameliorates substance P-induced hyperactive bladder via the inhibition of neutrophil NADPH oxidase activity. Neurosci. Lett. 402: 7-11, 2006.
7. Coe, F.L., A. Evan and E. Worcester. Kidney stone disease. J. Clin. Invest. 115: 2598-2608, 2005.
8. Ettinger, B., C.Y.C. Pak, J.T. Citron, C. Thomas, B. Dams-Huet and A. Vangessel. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 158: 2069-2073, 1997.
9. Freitas, A.M., N. Schor and M.A. Boim. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. Br J. Urol. Int. 89: 829-834, 2002.
10. Grover, P.K., R.L. Moritz, R.J. Simpson and R.L. Ryall. Inhibition of growth and aggregation of calcium oxalate crystals in vitro: A comparison of four human proteins. Eur. J. Biochem. 253: 637-644, 1998.
11. Hess, B., U. Meinhardt, L. Zipperle, R. Giovanoli and P. Jaeger. Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: Impact of various modifiers. Urol. Res. 21: 231-238, 1995.
12. Institute of Clinical Acupuncture and Oriental Medicine (ICAOM). Chinese herbal medicine formulas. Citation from: http://www.orientalmedicine.edu/ Formulas%20that%20Expel%20Dampness. pdf, 2006.
13. Joshia, V.S., B.B. Parekha, M.J. Joshia and A.B. Vaidyab. Herbal extracts of Tribulus terrestris and Bergenia ligulata inhibit growth of calcium oxalate monohydrate crystals in vitro. J. Cryst. Growth 275: 1403-1408, 2005.
14. Kano, Y., S. Takaguchi, T. Nohno, F. Hiragami, K. Kawamura, M.K. Iwama, K. Miyamoto and M. Takehara. Chinese medicine induces neurite outgrowth in PC12 mutant cells incapable of differentiation. Am. J. Chin. Med. 30: 287-295, 2002.
15. Kok, D.J., S.J. Papapoulos, L.J.M.J. Blomen and O.L.M. Bijvoet. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int. 34: 346-350, 1988.
16. Lee, Y.H., W.C. Huang, J.Y. Tsai, C.M. Lu, W.C Chen, M.H. Lee, H.S. Hsu, J.K. Huang and L.S. Chang. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol. Int. 68: 172-177, 2002.
17. Lewandowski, S. and A.L. Rodgers. Idiopathic calcium oxalate urolithiasis: Risk factors and conservative treatment. Clin. Chim. Acta 45: 17-34, 2004.
18. Ljungghall, S. and B.G. Danielson. A prospective study of renal stone recurrences. Br. J. Urol. 56: 122-124, 1984.
19. Nakagawa, Y., H.C. Margolis, S. Yokoyama, F.J. Kezdy, E.T. Kaiser and F.L. Coe. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J. Biol. Chem. 256: 3936-3944, 1981.
20. Schneider, H.J., W. Bothor, W. Berg, R.H. Borner and M. Jakob. A gel model for measuring crystallization inhibitor activities. Urol. Int. 38: 33-38, 1983.
21. Sutherland, J.W., J.H. Parks and F.L. Coe. Recurrence after a single renal stone in a community practice. Miner. Electrolyte Metab. 11: 267-269, 1985.
22. Suzuki, K., K. Kawamura and R. Tsugawa. Formation and growth inhibition of calcium oxalate crystals by Takusha (Alismatis Rhizoma). Scanning Microsc. 13: 183-189, 1999.
23. Uribarri, J., S. Man and J.H. Carroll. The first kidney stone. Ann. Int. Med. 111: 1006-1009, 1989.
24. Wilson, D.M. Clinical and laboratory approaches for evaluation of nephrolithiasis. J. Urol. 141: 770-774, 1989.
25. Yasui, T., K. Fujita, M. Sato, M. Sugimoto, M. Iguchi, S. Nomura and K. Kohri. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol. Res. 27: 194-199, 1999.